{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:26:11Z","timestamp":1781843171674,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jsat.2021.108288","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:05:27Z","timestamp":1610553927000},"page":"108288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study"],"prefix":"10.1016","volume":"124","author":[{"given":"Sarah B.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Dopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Ober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Uscher-Pines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108288_bb0005","series-title":"The CBHSQ Report: August 22, 2017","article-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update)","author":"Alderks","year":"2017"},{"key":"10.1016\/j.jsat.2021.108288_bb0010","author":"American Medical Association"},{"key":"10.1016\/j.jsat.2021.108288_bb0015","series-title":"Consensus statement on appropriate use of drug testing in clinical addiction medicine","author":"American Society of Addiction Medicine","year":"2017"},{"issue":"6","key":"10.1016\/j.jsat.2021.108288_bb0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/104973230201200611","article-title":"Matrix analysis as a complementary analytic strategy in qualitative inquiry","volume":"12","author":"Averill","year":"2002","journal-title":"Qualitative Health Research"},{"issue":"6","key":"10.1016\/j.jsat.2021.108288_bb0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: What the United States can learn from the global effort to treat opioid addiction","volume":"34","author":"Calcaterra","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2021.108288_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08897077.2020.1787300","article-title":"Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic","volume":"41","author":"Cochran","year":"2020","journal-title":"Substance Abuse"},{"issue":"7","key":"10.1016\/j.jsat.2021.108288_bb0035","first-page":"261","article-title":"Implementation of telepsychology services in a university training clinic: Process and lessons learned","volume":"40","author":"Dopp","year":"2017","journal-title":"The Behavior Therapist"},{"issue":"2","key":"10.1016\/j.jsat.2021.108288_bb0040","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08897077.2020.1752351","article-title":"Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment","volume":"41","author":"Green","year":"2020","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108288_bb0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: An experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"issue":"6","key":"10.1016\/j.jsat.2021.108288_bb0050","first-page":"1","article-title":"Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder","volume":"2","author":"Haffajee","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2021.108288_bb0055","author":"Hamilton"},{"key":"10.1016\/j.jsat.2021.108288_bb0060","doi-asserted-by":"crossref","first-page":"112516","DOI":"10.1016\/j.psychres.2019.112516","article-title":"Qualitative methods in implementation research: An introduction","volume":"280","author":"Hamilton","year":"2019","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jsat.2021.108288_bb0065","doi-asserted-by":"crossref","first-page":"107968","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108288_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2020.1624","article-title":"Comparison of driving times to opioid treatment programs and pharmacies in the US","author":"Kleinman","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2021.108288_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/10826084.2016.1267225","article-title":"Challenges to opioid treatment programs after Hurricane Sandy: Patient and provider perspectives on preparation, impact, and recovery","volume":"53","author":"Matusow","year":"2018","journal-title":"Substance Use and Misuse"},{"issue":"2","key":"10.1016\/j.jsat.2021.108288_bb0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/10826084.2017.1342662","article-title":"Medication-assisted treatment for opioid addiction in the United States: Critique and commentary","volume":"53","author":"McElrath","year":"2018","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.jsat.2021.108288_bb0085","author":"Mehrotra"},{"key":"10.1016\/j.jsat.2021.108288_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhealeco.2018.06.004","article-title":"The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion","volume":"60","author":"Meinhofer","year":"2018","journal-title":"Journal of Health Economics"},{"issue":"1","key":"10.1016\/j.jsat.2021.108288_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2021.108288_bb0100","article-title":"Flattening the curve by getting ahead of it: How the VA Healthcare System is leveraging telehealth to provide continued access to care for rural veterans","author":"Myers","year":"2020","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.jsat.2021.108288_bb0105","doi-asserted-by":"crossref","first-page":"948789","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States","volume":"2011","author":"Rosenblum","year":"2011","journal-title":"Journal of Environmental and Public Health"},{"key":"10.1016\/j.jsat.2021.108288_bb0110","series-title":"Federal guidelines for opioid treatment programs. HHS publication no. (SMA) PEP15-FEDGUIDEOTP","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.jsat.2021.108288_bb0115","series-title":"National survey of substance abuse treatment services (N-SSATS): 2019. Data on substance abuse treatment facilities","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"key":"10.1016\/j.jsat.2021.108288_bb0120","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"10","key":"10.1016\/j.jsat.2021.108288_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019993","article-title":"Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis","volume":"8","author":"Taylor","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jsat.2021.108288_bb0130","doi-asserted-by":"crossref","first-page":"108124","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2021.108288_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ADM.0b013e3182584772","article-title":"Methadone dose, take home status, and hospital admission among methadone maintenance patients","volume":"6","author":"Walley","year":"2012","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2021.108288_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1176\/appi.ps.201900150","article-title":"Relationship of county opioid epidemic severity to changes in access to substance use disorder treatment, 2009\u20132017","volume":"71","author":"Yarbrough","year":"2020","journal-title":"Psychiatric Services"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:14Z","timestamp":1760039594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"alternative-id":["S0740547221000143"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108288","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108288"}}